HOME >> BIOLOGY >> NEWS
Stanford researchers go from heaven to Earth in 'lifeguard' test

STANFORD, Calif. - Back in 2002, Stanford University engineers Kevin Montgomery, PhD, and Carsten Mundt, PhD, found themselves bored at a conference in Las Vegas. So they did what you'd expect from any researchers stuck in Sin City with frequent thoughts about life in outer space: They headed to a casino, downed a few cocktails and drew up a plan for the ideal physiological monitor for astronauts.

But here's what you wouldn't expect: The pair's scheme has come to life, a result of a Stanford-NASA collaboration to develop the physiological monitor and test it in a gamut of extreme environments. If the device passes NASA muster next year, it will become part of astronauts' wardrobes and will connect them to doctors who can monitor their health in real-time - something outside the realm of possibility given current NASA technology. Meanwhile, the team is using the device, called LifeGuard, to gather physiological data of use to the space program and is exploring terrestrial uses as well.

Today Montgomery, a researcher in the School of Medicine's surgery department, is director of engineering at the Stanford University-NASA National Center for Space Biological Technologies, and Mundt, also a researcher in surgery, is the center's chief hardware engineer. The center picks up where Montgomery and Mundt's previous collaborations with NASA left off.

At the time of the Las Vegas conference, Montgomery and Mundt had created a personal physiological monitor demo for John Hines, manager of the astrobionics program at NASA Ames in nearby Mountain View. "We used the demo to help engineers at NASA Johnson Space Center start figuring out what they'd need for the astronauts. They could play with it and zero in on the requirements," said Montgomery.

Though similar devices existed, none provided the wearability and functionality NASA required. After Montgomery and Mundt received the go-ahead fr
'"/>


15-Jun-2004


Page: 1 2 3

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Transplant rejection averted by simple light exposure in Stanford animal study
7. Fat cells heal skull defects in mice, Stanford research shows
8. Gene-based screen sorts cancer cases, say Stanford researchers
9. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
10. Sticklebacks reveal secrets to evolutionary change in Stanford study
11. Genetic screening study at Stanford IDs most aggressive adult leukemia strains

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 03, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... Ethicann Pharmaceuticals Inc. (“Ethicann”), a Calgary-based pharmaceutical company using botanically sourced cannabinoid ...
(Date:11/27/2019)... (PRWEB) , ... November 25, 2019 , ... Though the ... for the more than 55 million travelers expected to hit the roads and the ... application worth it’s weight in truffle oil will offer a simple design, mouth-watering pictures ...
(Date:11/22/2019)... N.Y. (PRWEB) , ... November 21, 2019 , ... ... developed at Roswell Park Comprehensive Cancer Center have announced a major step forward ... Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 17, 2019 , ... ... its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the company’s inception ... Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) have received 2 ...
(Date:12/18/2019)... ... 2019 , ... Tune in to CNBC on Saturday, December 28th at 11:00aET ... for more information on this program. , With a look at Avatar Partners ... system to increase the efficiency, safety and effectiveness of equipment, systems, and processes for ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System for ... suggests the CAPERE® offers great benefits for first-in-line treatment for nonsurgical removal ...
(Date:12/4/2019)... ... December 03, 2019 , ... Absolute Antibody ... a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert ... (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale. ...
Breaking Biology Technology:
Cached News: